Company Search:
Advanced Search
Sponsored Links
Apricus Biosciences Inc Company Snapshot
Apricus Biosciences Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apricus Biosciences Inc with three other companies in this sector in the United States: Elite Pharmaceuticals, Inc. (2015 sales of $5.02 million ), Alexza Pharmaceuticals, Inc. ($5.03 million of which 100% was Government Grants), and Targeted Medical Pharma Inc ($5.26 million ).

Sales Analysis. Apricus Biosciences Inc reported sales of $4.84 million for the year ending December of 2015. This represents a sharp decrease of 47.7% versus 2014, when the company's sales were $9.26 million. The sales level in 2015 was fairly close to the level five years ago: in 2010, Apricus Biosciences Inc had sales of $4.97 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Apricus Biosciences Inc
  Stock Performance Chart for Apricus Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): .35
(Figures in U.S. Dollars)
1 Week -13.2%   13 Weeks 2.9%  
4 Weeks -12.6%   52 Weeks -78.0%  
Apricus Biosciences Inc Key Data:
  Ticker: APRI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 4,839,000
(Year Ending Jan 2016).
Employees: 24
  Currency: U.S. Dollars Market Cap: 23,202,905
  Fiscal Yr Ends: December Shares Outstanding: 66,350,887
  Share Type: Common Closely Held Shares: 4,253,349
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.